Press Releases

Date	Title	Company
16-Dec-2022	Dupixent® (dupilumab) recommended for EU approval by the CHMP for the treatment of eosinophilic esophagitis	Sanofi
16-Dec-2022	AlzeCure gets late-breaking abstract on new data with its Alzheimer project Alzstatin accepted at AD/PD 2023	AlzeCure
16-Dec-2022	Qkine raises over £4M to scale manufacturing, R&D and commercial functions	Qkine
16-Dec-2022	Tiziana to Participate in January Investor Meetings	Tiziana Life Sciences Ltd
16-Dec-2022	Beiersdorf acquires S-Biomedic and strengthens expertise in the field of acne treatment	Beiersdorf
16-Dec-2022	CSL Receives Positive CHMP Opinion for Etranacogene Dezaparvovec – Gene Therapy for Adults with Hemophilia B	CSL
16-Dec-2022	RevoluGen Announces Distribution Agreement with BioEntist for Fire Monkey HMW-DNA Extraction Products in Thailand	RevoluGen
16-Dec-2022	Medical Ventilators Market to reach US$ 3.1 Bn by the end of 2030 \| Says FMI Analyst	MARKITWIRED
16-Dec-2022	Thin Film Drugs Market is geared to grow at a CAGR of 11% from 2023 to 2032 \| insightSLICE	insightSLICE
16-Dec-2022	Honey Dressings Market is geared to grow at a CAGR of 4.3% from 2023 to 2032 \| insightSLICE	insightSLICE
16-Dec-2022	Genomics Market exhibiting CAGR of 16% from 2023 to 2032, owing to the growing prevalence of cancer and genetic disorders \| insightSLICE	insightSLICE
16-Dec-2022	MENA Syringes & Cannula Market is expected to reach US$ 2.4 Bn by 2031, with CAGR 6.4%	MARKITWIRED
16-Dec-2022	Gel Stent Market is anticipated to expand at a CAGR of 7.2% from 2023 to 2032 \| insightSLICE	insightSLICE
16-Dec-2022	Cytokines Market is anticipated to expand at a CAGR of 6.3% from 2023 to 2032 \| insightSLICE	insightSLICE
16-Dec-2022	Audiology Devices Market to achieve CAGR of 6.4% from 2023 to 2032, owing to increasing prevalence of hearing impairment \| insightSLICE	insightSLICE
16-Dec-2022	Metered Dose Inhalers Market is predicted to advance at a CAGR of 4.3% from 2022 to 2032.	MARKITWIRED
16-Dec-2022	Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Market is set to expand 1.4X over the forecast years.	MARKITWIRED
16-Dec-2022	Alchemab Therapeutics and Medicines Discovery Catapult awarded £1.7 million grant from Innovate UK to accelerate development of disease-modifying therapy for Huntington’s Disease	Alchemab Therapeutics
16-Dec-2022	SmiLe alumni Acrivon AB’s US parent company Acrivon Therapeutics rings NASDAQ closing bell in New York	SmiLe
16-Dec-2022	Sosei Heptares and Lilly Enter Multi-target Collaboration and License Agreement in Diabetes and Metabolic Diseases	Sosei Heptares